Posted in | News | Mining Business

Samarco Mineração S.A. Breaks Monthly World Record in Iron Ore Pellet Production with its Metso Pelletizing Plant

Samarco Mineração S.A. has set a monthly production record during August 2023 of 824,829 tonnes of high-grade pellets in a single pelletizing line with its 816 m2 Metso Pelletizing Plant Indurating Machine #4 at its Ubu site in Brazil. At an annual level, the production is equivalent to approximately 8.8 to 9.0 Mtpa of pellets in a single machine. Samarco has installed three additional Metso Pelletizing Plants at its Ubu site.

“We’re very excited to see Samarco breaking their monthly iron ore pellet production record and would like to congratulate the whole team for this great achievement. It makes us proud to see how our solutions are helping our customers improve their pelletizing operations while simultaneously supporting the journey toward decarbonization,” says Pedro Sousa, Sales Manager, Ferrous & Heat Transfer, South America.

Currently, only the Plant #4 is in operation, and Samarco and Metso are discussing the revamp of the three other plants to continue increasing pellet production and decarbonizing the steel industry processes using sustainable technologies according to Samarco’s gradual production revamp plan. Related test works and studies are currently being performed at Metso’s R&D facility in Frankfurt, Germany.

Metso’s traveling grate pelletizing process produces uniform pellets, ensuring high performance and quality with low investment and operating costs, as well as decreased energy consumption and emissions.

Source: https://www.samarco.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.